Determination of d-limonene in mice plasma and tissues by a new GC-MS/MS method: Comparison of the pharmacokinetics and tissue distribution by oral and inhalation administration in mice.
Chen ChenYunhua ShengYue HuJie SunWei LiHongmin FengLiming TangPublished in: Biomedical chromatography : BMC (2019)
The aim of the present study was to develop a method based on gas chromatography-tandem mass spectrometry (GC-MS/MS) to determine and quantify the d-limonene in mouse plasma and tissue samples. This new method was validated for the quantification of d-limonene with the linearity ranges 1.0-1000.0 ng/mL (r2 > 0.9952) for plasma samples and 5.0-5000.0 ng/g (r2 > 0.9940) for tissue samples. The intra- and inter-day assay of precisions in plasma and tissues were <13.4% and the accuracies were within 91.1-105.8%. In the oral/inhalation administration pharmacokinetics and tissue distribution studies, the main pharmacokinetic parameters were the peak concentration = (97.150 ± 34.450)/(4336.415 ± 1142.418) ng/mL, the area under the curve = (162.828± 27.447)/(2085.721 ± 547.787) h ng/mL and the half-life = (3.196 ± 0.825)/(0.989 ± 0.095) h. The tissue distribution of d-limonene in mice after oral/inhalation administration demonstrated a decreasing tendency in different tissues (liver > kidney > heart > lung > spleen).
Keyphrases
- gas chromatography
- tandem mass spectrometry
- ultra high performance liquid chromatography
- ms ms
- solid phase extraction
- high performance liquid chromatography
- mass spectrometry
- gene expression
- liquid chromatography
- high fat diet induced
- simultaneous determination
- high resolution mass spectrometry
- heart failure
- high resolution
- liquid chromatography tandem mass spectrometry
- type diabetes
- insulin resistance
- atrial fibrillation
- adipose tissue
- clinical evaluation